535 USD
-6.34 (-1.17%)
534.25 USD
-0.75 (-0.14%)
ISRG gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 185 industry peers in the Health Care Equipment & Supplies industry. ISRG scores excellent points on both the profitability and health parts. This is a solid base for a good stock. ISRG is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings would make ISRG suitable for growth and quality investing!
1. Profitability
1.1 Basic Checks
- ISRG had positive earnings in the past year.
- ISRG had a positive operating cash flow in the past year.
- ISRG had positive earnings in each of the past 5 years.
- In the past 5 years ISRG always reported a positive cash flow from operatings.
1.2 Ratios
- The Return On Assets of ISRG (14.19%) is better than 96.22% of its industry peers.
- ISRG has a better Return On Equity (16.12%) than 91.35% of its industry peers.
- ISRG has a Return On Invested Capital of 14.96%. This is amongst the best in the industry. ISRG outperforms 95.14% of its industry peers.
- ISRG had an Average Return On Invested Capital over the past 3 years of 12.20%. This is above the industry average of 8.84%.
- The 3 year average ROIC (12.20%) for ISRG is below the current ROIC(14.96%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.19% | ||
| ROE | 16.12% | ||
| ROIC | 14.96% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)12.2%
ROIC(5y)11.86%
1.3 Margins
- The Profit Margin of ISRG (28.58%) is better than 96.76% of its industry peers.
- ISRG's Profit Margin has declined in the last couple of years.
- Looking at the Operating Margin, with a value of 29.44%, ISRG belongs to the top of the industry, outperforming 96.76% of the companies in the same industry.
- In the last couple of years the Operating Margin of ISRG has declined.
- ISRG has a better Gross Margin (66.38%) than 70.27% of its industry peers.
- In the last couple of years the Gross Margin of ISRG has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 29.44% | ||
| PM (TTM) | 28.58% | ||
| GM | 66.38% |
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ISRG is creating some value.
- ISRG has more shares outstanding than it did 1 year ago.
- ISRG has more shares outstanding than it did 5 years ago.
- ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | N/A |
ROIC/WACC1.51
WACC9.9%
2.3 Liquidity
- ISRG has a Current Ratio of 4.97. This indicates that ISRG is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Current ratio, with a value of 4.97, ISRG is in the better half of the industry, outperforming 78.92% of the companies in the same industry.
- A Quick Ratio of 4.20 indicates that ISRG has no problem at all paying its short term obligations.
- The Quick ratio of ISRG (4.20) is better than 77.84% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.97 | ||
| Quick Ratio | 4.2 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 28.12% over the past year.
- Measured over the past years, ISRG shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.48% on average per year.
- The Revenue has grown by 22.18% in the past year. This is a very strong growth!
- The Revenue has been growing by 13.27% on average over the past years. This is quite good.
EPS 1Y (TTM)28.12%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%30.43%
Revenue 1Y (TTM)22.18%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%22.91%
3.2 Future
- The Earnings Per Share is expected to grow by 15.67% on average over the next years. This is quite good.
- ISRG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.12% yearly.
EPS Next Y20.12%
EPS Next 2Y16.35%
EPS Next 3Y15.9%
EPS Next 5Y15.67%
Revenue Next Year21.32%
Revenue Next 2Y18.09%
Revenue Next 3Y16.5%
Revenue Next 5Y14.12%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 62.14, ISRG can be considered very expensive at the moment.
- Based on the Price/Earnings ratio, ISRG is valued a bit cheaper than the industry average as 67.03% of the companies are valued more expensively.
- Compared to an average S&P500 Price/Earnings ratio of 27.54, ISRG is valued quite expensively.
- The Price/Forward Earnings ratio is 53.91, which means the current valuation is very expensive for ISRG.
- 68.11% of the companies in the same industry are more expensive than ISRG, based on the Price/Forward Earnings ratio.
- Compared to an average S&P500 Price/Forward Earnings ratio of 24.31, ISRG is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 62.14 | ||
| Fwd PE | 53.91 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, ISRG is valued a bit cheaper than the industry average as 65.41% of the companies are valued more expensively.
- ISRG's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ISRG is cheaper than 70.81% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 83.5 | ||
| EV/EBITDA | 53.2 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ISRG does not grow enough to justify the current Price/Earnings ratio.
- The excellent profitability rating of ISRG may justify a higher PE ratio.
- ISRG's earnings are expected to grow with 15.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.09
PEG (5Y)5.41
EPS Next 2Y16.35%
EPS Next 3Y15.9%
5. Dividend
5.1 Amount
- ISRG does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
535
-6.34 (-1.17%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-21 2025-10-21/amc
Earnings (Next)01-22 2026-01-22/amc
Inst Owners88.29%
Inst Owner Change0.45%
Ins Owners0.45%
Ins Owner Change1%
Market Cap189.66B
Revenue(TTM)9.61B
Net Income(TTM)2.75B
Analysts77
Price Target616.63 (15.26%)
Short Float %1.98%
Short Ratio3.36
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.16%
Min EPS beat(2)11.61%
Max EPS beat(2)18.71%
EPS beat(4)4
Avg EPS beat(4)13.53%
Min EPS beat(4)3.05%
Max EPS beat(4)20.76%
EPS beat(8)8
Avg EPS beat(8)11%
EPS beat(12)11
Avg EPS beat(12)7.6%
EPS beat(16)13
Avg EPS beat(16)5.75%
Revenue beat(2)2
Avg Revenue beat(2)2%
Min Revenue beat(2)1.84%
Max Revenue beat(2)2.17%
Revenue beat(4)4
Avg Revenue beat(4)2.55%
Min Revenue beat(4)1.09%
Max Revenue beat(4)5.12%
Revenue beat(8)5
Avg Revenue beat(8)1.17%
Revenue beat(12)6
Avg Revenue beat(12)0.55%
Revenue beat(16)8
Avg Revenue beat(16)0.31%
PT rev (1m)0.52%
PT rev (3m)3.21%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.15%
EPS NY rev (1m)0%
EPS NY rev (3m)5.8%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.65%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)1.3%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 62.14 | ||
| Fwd PE | 53.91 | ||
| P/S | 19.73 | ||
| P/FCF | 83.5 | ||
| P/OCF | 64.06 | ||
| P/B | 11.13 | ||
| P/tB | 11.36 | ||
| EV/EBITDA | 53.2 |
EPS(TTM)8.61
EY1.61%
EPS(NY)9.92
Fwd EY1.85%
FCF(TTM)6.41
FCFY1.2%
OCF(TTM)8.35
OCFY1.56%
SpS27.11
BVpS48.07
TBVpS47.09
PEG (NY)3.09
PEG (5Y)5.41
Graham Number96.5
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.19% | ||
| ROE | 16.12% | ||
| ROCE | 16.61% | ||
| ROIC | 14.96% | ||
| ROICexc | 29.62% | ||
| ROICexgc | 30.86% | ||
| OM | 29.44% | ||
| PM (TTM) | 28.58% | ||
| GM | 66.38% | ||
| FCFM | 23.63% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)12.2%
ROIC(5y)11.86%
ROICexc(3y)18.44%
ROICexc(5y)19.03%
ROICexgc(3y)19.29%
ROICexgc(5y)20.12%
ROCE(3y)13.54%
ROCE(5y)13.16%
ROICexgc growth 3Y-7.59%
ROICexgc growth 5Y-7%
ROICexc growth 3Y-6.87%
ROICexc growth 5Y-6.06%
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
F-Score8
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 111.36% | ||
| Cap/Sales | 7.17% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 85.84% | ||
| Profit Quality | 82.69% | ||
| Current Ratio | 4.97 | ||
| Quick Ratio | 4.2 | ||
| Altman-Z | N/A |
F-Score8
WACC9.9%
ROIC/WACC1.51
Cap/Depr(3y)197.35%
Cap/Depr(5y)162.98%
Cap/Sales(3y)12.27%
Cap/Sales(5y)10.16%
Profit Quality(3y)56.77%
Profit Quality(5y)75.99%
High Growth Momentum
Growth
EPS 1Y (TTM)28.12%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%30.43%
EPS Next Y20.12%
EPS Next 2Y16.35%
EPS Next 3Y15.9%
EPS Next 5Y15.67%
Revenue 1Y (TTM)22.18%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%22.91%
Revenue Next Year21.32%
Revenue Next 2Y18.09%
Revenue Next 3Y16.5%
Revenue Next 5Y14.12%
EBIT growth 1Y36.82%
EBIT growth 3Y8.76%
EBIT growth 5Y11.37%
EBIT Next Year45.96%
EBIT Next 3Y24.75%
EBIT Next 5Y20.85%
FCF growth 1Y80.69%
FCF growth 3Y-9.1%
FCF growth 5Y2.14%
OCF growth 1Y46.32%
OCF growth 3Y4.95%
OCF growth 5Y8.61%
INTUITIVE SURGICAL INC / ISRG FAQ
Can you provide the ChartMill fundamental rating for INTUITIVE SURGICAL INC?
ChartMill assigns a fundamental rating of 7 / 10 to ISRG.
What is the valuation status of INTUITIVE SURGICAL INC (ISRG) stock?
ChartMill assigns a valuation rating of 4 / 10 to INTUITIVE SURGICAL INC (ISRG). This can be considered as Fairly Valued.
How profitable is INTUITIVE SURGICAL INC (ISRG) stock?
INTUITIVE SURGICAL INC (ISRG) has a profitability rating of 8 / 10.
What are the PE and PB ratios of INTUITIVE SURGICAL INC (ISRG) stock?
The Price/Earnings (PE) ratio for INTUITIVE SURGICAL INC (ISRG) is 62.14 and the Price/Book (PB) ratio is 11.13.
Can you provide the financial health for ISRG stock?
The financial health rating of INTUITIVE SURGICAL INC (ISRG) is 7 / 10.